🔬
🔬 Science
AI-designed "intrabodies" could unlock treatments for Alzheimer's and Parkinson's
Researchers have used artificial intelligence to develop a method for converting ordinary antibodies into tiny molecules capable of operating inside human cells. These so-called "intrabodies" could open new treatment pathways for Alzheimer's, Parkinson's, Huntington's disease, and motor neurone disease. Until now, antibodies have been unable to function effectively inside cells, making this a significant breakthrough in drug design.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!